Women's Health market research reports by DelveInsight

• Postpartum Depression - Epidemiology Forecast to 2032

  Jan 01, 2022  |  Published by: DelveInsight  |  USD 3,950

  DelveInsight's "" Postpartum Depression - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Postpartum Depression epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japa ... Read More

• HPV16-positive Anogenital Cancer - Epidemiology Forecast - 2032

  Jan 01, 2022  |  Published by: DelveInsight  |  USD 3,950

  DelveInsight's "" HPV16-positive Anogenital Cancer - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted HPV16-positive Anogenital Cancer epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the Uni ... Read More

• Cervical Cancer Epidemiology Forecast to 2032

  Jan 01, 2022  |  Published by: DelveInsight  |  USD 3,950

  DelveInsight's "" Cervical Cancer - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Cervical Cancer epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geograp ... Read More

• Platinum-resistant relapsed ovarian cancer - Epidemiology Forecast - 2032

  Jan 01, 2022  |  Published by: DelveInsight  |  USD 3,950

  DelveInsight's "" Platinum-resistant relapsed ovarian cancer - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Platinum-resistant relapsed ovarian cancer epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, ... Read More

• Recurrent or Metastatic HER2-Overexpressing Solid Tumors - Epidemiology Forecast - 2032

  Jan 01, 2022  |  Published by: DelveInsight  |  USD 3,950

  DelveInsight's "" Recurrent or Metastatic HER2-Overexpressing Solid Tumors - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Recurrent or Metastatic HER2-Overexpressing Solid Tumors epidemiology in the 7MM, i.e., the United States, ... Read More

• HER2-Negative Breast Cancer - Epidemiology Forecast to 2032

  Jan 01, 2022  |  Published by: DelveInsight  |  USD 3,950

  DelveInsight's "" HER2-Negative Breast Cancer - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted HER2-Negative Breast Cancer epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdo ... Read More

• ESR1 Mutated Metastatic Breast Cancer - Market Insight, Epidemiology and Market Forecast -2032

  Jan 01, 2022  |  Published by: DelveInsight  |  USD 7,500

  DelveInsight's "" ESR1 Mutated Metastatic Breast Cancer- Market Insights, Epidemiology, and Market Forecast-2032 "" report delivers an in-depth understanding of the ESR1 Mutated Metastatic Breast Cancer, historical and forecasted epidemiology as well as the ESR1 Mutated Metastatic Breast Cancer mark ... Read More

• Metastatic HER2 positive breast cancer - Epidemiology Forecast to 2032

  Jan 01, 2022  |  Published by: DelveInsight  |  USD 3,950

  DelveInsight's "" Metastatic HER2 positive breast cancer - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Metastatic HER2 positive breast cancer epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, ... Read More

• Metastatic HER2 positive breast cancer - Market Insight, Epidemiology and Market Forecast -2032

  Jan 01, 2022  |  Published by: DelveInsight  |  USD 7,500

  DelveInsight's "" Metastatic HER2 positive breast cancer- Market Insights, Epidemiology, and Market Forecast-2032 "" report delivers an in-depth understanding of the Metastatic HER2 positive breast cancer, historical and forecasted epidemiology as well as the Metastatic HER2 positive breast cancer m ... Read More

• Endometriosis - Epidemiology Forecast to 2032

  Jan 01, 2022  |  Published by: DelveInsight  |  USD 3,950

  DelveInsight's "" Endometriosis - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Endometriosis epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies C ... Read More

• ESR1 Mutated Metastatic Breast Cancer - Epidemiology Forecast to 2032

  Jan 01, 2022  |  Published by: DelveInsight  |  USD 3,950

  DelveInsight's "" ESR1 Mutated Metastatic Breast Cancer - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted ESR1 Mutated Metastatic Breast Cancer epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, a ... Read More

• HR-Positive-HER-negative - Epidemiology Forecast to 2032

  Jan 01, 2022  |  Published by: DelveInsight  |  USD 3,950

  DelveInsight's "" HR-Positive-HER-negative - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted HR-Positive-HER-negative epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), an ... Read More

• Advanced Recurrent Ovarian Cancer - Epidemiology Forecast to 2032

  Jan 01, 2022  |  Published by: DelveInsight  |  USD 3,950

  DelveInsight's "" Advanced Recurrent Ovarian Cancer - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Advanced Recurrent Ovarian Cancer epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the U ... Read More

< prev 1 2 3 4 5 next >